BOHAI PHARMACEUTICAL (OTCMKTS:BOPH) Shorts Decreased by 78.57% After Short Covering

June 19, 2017 - By Vivian Park

The stock of BOHAI PHARMACEUTICAL (OTCMKTS:BOPH) registered a decrease of 78.57% in short interest. BOPH’s total short interest was 600 shares in June as published by FINRA. Its down 78.57% from 2,800 shares, reported previously. With 900 shares average volume, it will take short sellers 1 days to cover their BOPH’s short positions.

It closed at $0.49 lastly. It is down 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Bohai Pharmaceuticals Group, Inc. is a maker and marketer of herb pharmaceutical formulations based on traditional Chinese medicine . The company has market cap of $9.57 million. The Company’s medicines address rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. It has a 0.45 P/E ratio. The Firm produces seven varieties of traditional Chinese herbal medicines in seven delivery systems: tablets, granules, capsules, formulations, concentrated powder, tincture and medicinal wine.

More news for Bohai Pharmaceuticals Group, Inc. (OTCMKTS:BOPH) were recently published by: Seekingalpha.com, which released: “What Have We Learned From Bohai Pharmaceuticals?” on May 16, 2015. Law360.com‘s article titled: “Bohai Pharma Hit With Suit Claiming Securities Shenanigans” and published on June 09, 2015 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.